Hypoxia and drug resistance
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 13 (2) , 139-168
- https://doi.org/10.1007/bf00689633
Abstract
Biologically and therapeutically important hypoxia occurs in many solid tumor masses. Hypoxia can be a direct cause of therapeutic resistance because some drugs and radiation require oxygen to be maximally cytotoxic. Cellular metabolism is altered under hypoxic conditions. Hypoxia can result in drug resistance indirectly if under this condition cells more effectively detoxify the drug molecules. Finally, there is evidence that hypoxia can enhance genetic instability in tumor cells thus allowing more rapid development of drug resistance cells. The current review describes the effects of hypoxia on tumor response to a variety of anticancer agents and also describes progress toward therapeutically useful methods of delivering oxygen to tumors in an effort to overcome therapeutic resistance due to hypoxia. Finally, the use of hypoxic cell selective cytotoxic agents as a means of addressing hypoxic ‘drug resistance’ is discussed.Keywords
This publication has 178 references indexed in Scilit:
- Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathingZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Oxygenation of the Rat 9l Gliosarcoma and the Rat 13672 Mammary Carcinoma with Various Doses of a Hemoglobin SolutionArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1994
- Taxol and taxotere—Current status and future prospectsEuropean Journal Of Cancer, 1993
- A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agentsZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Drug Resistance in Chinese Hamster Ovary Cells During Recovery From Severe HypoxiaJNCI Journal of the National Cancer Institute, 1989
- C-Fos expression in human skin fibroblasts by reperfusion after oxygen deficiency; A recovery change of human skin fibroblasts after oxygen deficiency stressBiochemical and Biophysical Research Communications, 1987
- Cyclophosphamide (Cytoxan)Journal of the American Academy of Dermatology, 1984
- Production of free radicals from phenol and tocopherol by bleomycin-iron(II) complexBiochemical and Biophysical Research Communications, 1979
- The mechanism of the bleomycin-induced cleavage of DNABiochemical and Biophysical Research Communications, 1977
- Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agentsBiochemical and Biophysical Research Communications, 1977